David M. Vail

ORCID: 0000-0002-1964-3693

Also affiliated with University of Wisconsin Carbone Cancer Center

MedicineBiochemistry, Genetics and Molecular BiologyVeterinary

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Advanced Cancer Imaging Applied in the Comparative Setting”.

Advanced Cancer Imaging Applied in the Comparative Setting

Frontiers in Oncology(2020)10.3389/fonc.2020.00084

N/A

0DataRank · unranked

10 citations

Amy K. LeBlanc, Robert Jeraj, David M. Vail

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

Veterinary and Comparative Oncology(2021)10.1111/vco.12677

N/A

0DataRank · unranked

325 citations

Matthew J. Atherton, R. Timothy Bentley, C. Elizabeth Boudreau, Jenna H. Burton, Kaitlin M. Curran +15 more

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Science Translational Medicine(2021)10.1126/scitranslmed.abb3631

N/A

0DataRank · unranked

233 citations

Reinier Hernandez, Peter M. Carlson, Joseph J. Grudzinski, Amber M. Bates, Justin C. Jagodinsky +17 more

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0315

N/A

0DataRank · unranked

55 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

PLoS ONE(2021)10.1371/journal.pone.0255798

N/A

0DataRank · unranked

39 citations

Ian R. Marsh, Michelle Turek, Joseph J. Grudzinski, Eduardo Aluicio‐Sarduy, Jonathan W. Engle +13 more

Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing Dogs

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0167

N/A

0DataRank · unranked

10 citations

Christina Mazcko, Timothy M. Fan, David M. Vail, Brian K. Flesner, Jeffrey N. Bryan +14 more

862 Administration of intratumoral hu14.18-IL2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0862

N/A

0DataRank · unranked

0 citations

Cindy Zuleger, Erik A. Ranheim, Oyewale Shiyanbola, Andrew T. Kosharek, Paul M. Sondel +12 more

Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs

Veterinary Immunology and Immunopathology(2023)10.1016/j.vetimm.2023.110691

N/A

0DataRank · unranked

8 citations

Stephen Albert Johnston, David M. Vail, Jens C. Eickhoff, Kathryn Sykes, Justin R. Brown +15 more

Development of a next-generation sequencing protocol for the canine T cell receptor beta chain repertoire

Veterinary Immunology and Immunopathology(2023)10.1016/j.vetimm.2023.110702

N/A

0DataRank · unranked

3 citations

Rene Welch, Irene M. Ong, Michael A. Newton, David M. Vail, Mark R. Albertini +1 more

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Data from Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

(2023)10.1158/1078-0432.c.6529898.v1

N/A

0DataRank · unranked

0 citations

Christina Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown +39 more

Feasibility and optimization of 19 F MRI on a clinical 3T with a large field-of-view torso coil

Physics in Medicine and Biology(2024)10.1088/1361-6560/ad4d50

N/A

0DataRank · unranked

2 citations

Monica M. Cho, David M. Vail, Christian M Captini, Sean B. Fain, Paul Begovatz +1 more

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Melanoma Research(2024)10.1097/cmr.0000000000000975

N/A

0DataRank · unranked

7 citations

Cindy Zuleger, Erik A. Ranheim, Oyewale Shiyanbola, Paul M. Sondel, Zachary S. Morris +9 more

Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2

Molecular Therapy(2025)10.1016/j.ymthe.2025.02.023

N/A

0DataRank · unranked

11 citations

Laura E. Selmic, Audrey Ruple, Cheryl A. London, Lisa G. Barber, Kristen Weishaar +28 more

Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles

Frontiers in Immunology(2025)10.3389/fimmu.2025.1571085

N/A

0DataRank · unranked

10 citations

Marshall Lammers, Sean J. Judge, William J. Murphy, Cameron E. Gaskill, William T. N. Culp +8 more

Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials

Frontiers in Immunology(2025)10.3389/fimmu.2025.1646849

N/A

0DataRank · unranked

1 citations

Marshall Lammers, Sean J. Judge, Cyrus J. Sholevar, William J. Murphy, Cameron E. Gaskill +9 more

In vitro detection of canine anti-human antibodies following intratumoral injection of the hu14.18-IL2 immunocytokine in spontaneous canine melanoma

PLoS ONE(2025)10.1371/journal.pone.0330200

N/A

0DataRank · unranked

0 citations

Cindy Zuleger, William S. Glass, Jens C. Eickhoff, Paul M. Sondel, David M. Vail +2 more

Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma

Frontiers in Immunology(2025)10.3389/fimmu.2025.1672790

N/A

0DataRank · unranked

0 citations

Sylvia M. Cruz, Daniel York, Christina Mazcko, Aryana M. Razmara, Sushant Patkar +24 more

SatTCR: a pipeline for performing saturation analysis of the T cell receptor repertoire and a case study of a healthy canine

MethodsX(2025)10.1016/j.mex.2025.103733

N/A

0DataRank · unranked

0 citations

Cindy Zuleger, Michael A. Newton, David M. Vail, Mark R. Albertini, Irene M. Ong +1 more